LobbyingAgiliti lobbying by quarter
Agiliti's latest lobbying report covers Q2 2026, at $30K. Its first report covers Q2 2026; the issues it reports most are Health Issues and Medicare/Medicaid.
Agiliti
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $30K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$15K · 1 reports
- Medicare and Medicaid$15K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)1 reports
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Liberty Partners Group | $30K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANDREW COATS | Legislative Assistant, Rep. Mark Souder | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Liberty Partners Group | $30K |
| 07/20for Q2 | Liberty Partners Group | Under $5,000 |
| 07/03for Q3 2025 | Liberty Partners Group | Under $5,000 |